This joint white paper recommends the implementation of well-designed NFC systems coupled with legislative liability protections for pandemic vaccines to ensure both equitable compensation and adequate vaccine coverage in a future pandemic.
Read moreDiscover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read moreOn 28 February, IFPMA delivered a statement at the fourth meeting of the Intergovernmental Negotiating Body (INB) for a WHO instrument on pandemic prevention, preparedness and response held from 27 February - 3 March 2023.
Read more